A detailed history of Integrated Investment Consultants, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 6,938 shares of ABBV stock, worth $1.34 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
6,938
Previous 6,938 -0.0%
Holding current value
$1.34 Million
Previous $1.26 Million 5.78%
% of portfolio
0.35%
Previous 0.37%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $36,119 - $41,154
-226 Reduced 3.15%
6,938 $1.26 Million
Q4 2023

May 28, 2024

BUY
$137.6 - $154.97 $1,238 - $1,394
9 Added 0.13%
6,919 $1.07 Million
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $14,998 - $16,891
109 Added 1.55%
7,164 $1.11 Million
Q3 2023

May 28, 2024

SELL
$133.59 - $154.65 $3,740 - $4,330
-28 Reduced 0.4%
6,910 $1.03 Million
Q3 2023

Oct 17, 2023

SELL
$133.59 - $154.65 $29,656 - $34,332
-222 Reduced 3.05%
7,055 $1.05 Million
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $125,751 - $156,490
-949 Reduced 11.54%
7,277 $980,000
Q1 2023

Jul 18, 2023

BUY
$144.61 - $166.54 $108,312 - $124,738
749 Added 10.29%
8,026 $1.28 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $45,918 - $55,068
332 Added 4.21%
8,226 $1.33 Million
Q3 2022

Nov 21, 2022

SELL
$134.21 - $153.93 $52,073 - $59,724
-388 Reduced 4.68%
7,894 $1.06 Million
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $93,031 - $118,272
-676 Reduced 7.55%
8,282 $1.27 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $80,375 - $99,723
-609 Reduced 6.37%
8,958 $1.45 Million
Q4 2021

Jan 10, 2022

SELL
$107.43 - $135.93 $123,437 - $156,183
-1,149 Reduced 10.72%
9,567 $1.3 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $3,724 - $4,227
35 Added 0.33%
10,716 $1.16 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $119,097 - $132,681
1,132 Added 11.85%
10,681 $1.2 Million
Q1 2021

Apr 20, 2021

SELL
$102.3 - $112.62 $50,945 - $56,084
-498 Reduced 4.96%
9,549 $1.03 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $42,418 - $57,269
527 Added 5.54%
10,047 $1.08 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $26,975 - $31,660
-314 Reduced 3.19%
9,520 $834,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $7,997 - $10,701
109 Added 1.12%
9,834 $966,000
Q1 2020

May 22, 2020

SELL
$64.5 - $97.79 $42,699 - $64,736
-662 Reduced 6.37%
9,725 $741,000
Q4 2019

Jan 29, 2020

SELL
$72.13 - $90.25 $10,458 - $13,086
-145 Reduced 1.38%
10,387 $920,000
Q3 2019

Oct 21, 2019

SELL
$62.98 - $75.72 $12,596 - $15,144
-200 Reduced 1.86%
10,532 $797,000
Q2 2019

Jul 16, 2019

SELL
$65.7 - $83.98 $121,413 - $155,195
-1,848 Reduced 14.69%
10,732 $780,000
Q1 2019

Apr 26, 2019

SELL
$77.14 - $90.79 $6,325 - $7,444
-82 Reduced 0.65%
12,580 $1.01 Million
Q4 2018

Feb 04, 2019

BUY
$77.85 - $96.01 $10,198 - $12,577
131 Added 1.05%
12,662 $1.17 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $5.26 Million - $6.22 Million
-58,578 Reduced 82.38%
12,531 $1.16 Million
Q2 2018

Aug 01, 2018

BUY
$89.78 - $106.23 $5.24 Million - $6.2 Million
58,375 Added 458.42%
71,109 $1.24 Million
Q1 2018

Apr 12, 2018

SELL
$92.01 - $123.21 $5,980 - $8,008
-65 Reduced 0.51%
12,734 $1.21 Million
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $894,010 - $1.14 Million
12,799
12,799 $1.14 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Integrated Investment Consultants, LLC Portfolio

Follow Integrated Investment Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.